SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Dupont E I De Nemours & Co – ‘10-Q’ for 3/31/17 – ‘EX-32.1’

On:  Tuesday, 4/25/17, at 3:28pm ET   ·   For:  3/31/17   ·   Accession #:  30554-17-16   ·   File #:  1-00815

Previous ‘10-Q’:  ‘10-Q’ on 10/25/16 for 9/30/16   ·   Next:  ‘10-Q’ on 7/25/17 for 6/30/17   ·   Latest:  ‘10-Q’ on 11/9/23 for 9/30/23   ·   1 Reference:  By:  Corteva, Inc. – ‘10-K’ on 2/11/21 for 12/31/20

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 4/25/17  Dupont E I De Nemours & Co        10-Q        3/31/17   81:9.5M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    527K 
 2: EX-10.16    Material Contract                                   HTML    114K 
 3: EX-10.23    Material Contract                                   HTML    140K 
 4: EX-10.25    Material Contract                                   HTML   1.17M 
 5: EX-12       Statement re: Computation of Ratios                 HTML     32K 
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     32K 
 7: EX-31.2     Certification -- §302 - SOA'02                      HTML     32K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     26K 
 9: EX-32.2     Certification -- §906 - SOA'02                      HTML     26K 
16: R1          Document and Entity Information                     HTML     43K 
17: R2          Consolidated Income Statements                      HTML     91K 
18: R3          Consolidated Statements of Comprehensive Income     HTML     52K 
19: R4          Condensed Consolidated Balance Sheets               HTML    121K 
20: R5          Condensed Consolidated Balance Sheets               HTML     36K 
                (Parenthetical)                                                  
21: R6          Condensed Consolidated Statements of Cash Flows     HTML    103K 
22: R7          Summary of Significant Accounting Policies          HTML     47K 
23: R8          Planned Merger with Dow Chemical Planned Merger     HTML     38K 
                with Dow Chemical                                                
24: R9          Divestitures and Other Transactions                 HTML     38K 
25: R10         Employee Separation / Asset Related Charges, Net    HTML     65K 
26: R11         Other Income, Net                                   HTML     62K 
27: R12         Provision for Income Taxes                          HTML     30K 
28: R13         Earnings Per Share of Common Stock                  HTML     51K 
29: R14         Inventories                                         HTML     35K 
30: R15         Other Intangible Assets                             HTML     79K 
31: R16         Short-Term and Long-Term Borrowings                 HTML     31K 
32: R17         Commitments and Contingent Liabilities              HTML     83K 
33: R18         Stockholders' Equity                                HTML    133K 
34: R19         Financial Instruments                               HTML    142K 
35: R20         Long-Term Employee Benefits                         HTML     58K 
36: R21         Segment Information                                 HTML    101K 
37: R22         Summary of Significant Accounting Policies Summary  HTML     47K 
                of Significant Accounting Policies (Policies)                    
38: R23         Employee Separation / Asset Related Charges, Net    HTML     61K 
                (Tables)                                                         
39: R24         Other Income, Net (Tables)                          HTML     62K 
40: R25         Earnings Per Share of Common Stock (Tables)         HTML     52K 
41: R26         Inventories (Tables)                                HTML     36K 
42: R27         Other Intangible Assets (Tables)                    HTML     76K 
43: R28         Commitments and Contingent Liabilities (Tables)     HTML     52K 
44: R29         Stockholders' Equity (Tables)                       HTML    130K 
45: R30         Financial Instruments (Tables)                      HTML    129K 
46: R31         Long-Term Employee Benefits (Tables)                HTML     57K 
47: R32         Segment Information (Tables)                        HTML    102K 
48: R33         Summary of Significant Accounting Policies Summary  HTML     33K 
                of Significant Accounting Policies (Narrative)                   
                (Details)                                                        
49: R34         Planned Merger with Dow Chemical Planned Merger     HTML     36K 
                with Dow Chemical (Narrative) (Details)                          
50: R35         Divestitures and Other Transactions (Narrative)     HTML     56K 
                (Details)                                                        
51: R36         Employee Separation / Asset Related Charges, Net    HTML     61K 
                Employee Separation / Asset Related Charges, Net                 
                (2017 Restructuring Program schedule) (Details)                  
52: R37         Employee Separation / Asset Related Charges, Net    HTML     36K 
                Employee Separation / Asset Related Charges, Net                 
                (La Porte) (Narrative) (Details)                                 
53: R38         Employee Separation / Asset Related Charges, Net    HTML     66K 
                Employee Separation / Asset Related Charges, Net                 
                (2016 Restructuring Program schedule )(Details)                  
54: R39         Other Income, Net (Schedule of Other Income)        HTML     66K 
                (Details)                                                        
55: R40         Other Income, Net (Schedule of Foreign Exchange     HTML     36K 
                Gain (Loss)) (Details)                                           
56: R41         Provision for Income Taxes (Details)                HTML     32K 
57: R42         Earnings Per Share of Common Stock (Earnings Per    HTML     48K 
                Share of Common Stock Reconciliation) (Details)                  
58: R43         Earnings Per Share of Common Stock (Schedule of     HTML     29K 
                Average Number of Antidilutive Stock Options)                    
                (Details)                                                        
59: R44         Inventories (Details)                               HTML     37K 
60: R45         Other Intangible Assets (Schedule of Other          HTML     66K 
                Intangible Assets) (Details)                                     
61: R46         Other Intangible Assets (Narrative) (Details)       HTML     44K 
62: R47         Short-Term and Long-Term Borrowings (Details)       HTML     57K 
63: R48         Commitments and Contingent Liabilities              HTML     55K 
                (Guarantees) (Details)                                           
64: R49         Commitments and Contingent Liabilities              HTML    122K 
                (Litigation) (Narrative) (Details)                               
65: R50         Commitments and Contingent Liabilities Commitments  HTML     38K 
                and Contingent Liabilities (Environmental)                       
                (Narrative) (Details)                                            
66: R51         Stockholders' Equity Stockholder's Equity           HTML     59K 
                (Details)                                                        
67: R52         Stockholders' Equity Stockholder's Equity           HTML     30K 
                (Schedule of tax benefit (Expense) on Net                        
                Activity) (Details) (Details)                                    
68: R53         Stockholders' Equity Stockholders' Equity           HTML     68K 
                (Reclassifications out of accumulated other                      
                Comprehensive Income / (Loss)) (Details) (Details)               
69: R54         Financial Instruments Financial Insttruments        HTML     51K 
                (Schedule of Cash, Cash Equivalents and Marketable               
                Securities) (Details)                                            
70: R55         Financial Instruments (Debt) (Narrative) (Details)  HTML     26K 
71: R56         Financial Instruments (Notional Amounts of          HTML     32K 
                Derivatives) (Details)                                           
72: R57         Financial Instruments (Effect of Cash Flows Hedges  HTML     38K 
                on Accumulated Other Comprehensive Income (Loss))                
                (Details)                                                        
73: R58         Financial Instruments (Schedule of the Fair Value   HTML     52K 
                of Derivative Instruments) (Details)                             
74: R59         Financial Instruments (Effect of Derivative         HTML     52K 
                Instruments) (Details)                                           
75: R60         Long-Term Employee Benefits (Schedules of Net       HTML     59K 
                Periodic Benefit Cost) (Details)                                 
76: R61         Segment Information (Schedule of Segment            HTML     48K 
                Information) (Details)                                           
77: R62         Segment Information (Reconciliation to              HTML     68K 
                Consolidated Income Statements) (Details)                        
78: R63         Segment Information (Significant Pre-tax (charges)  HTML     86K 
                benefits not included in Segment Operating                       
                Earnings) (Details)                                              
80: XML         IDEA XML File -- Filing Summary                      XML    143K 
79: EXCEL       IDEA Workbook of Financial Reports                  XLSX     89K 
10: EX-101.INS  XBRL Instance -- dd-20170331                         XML   2.43M 
12: EX-101.CAL  XBRL Calculations -- dd-20170331_cal                 XML    198K 
13: EX-101.DEF  XBRL Definitions -- dd-20170331_def                  XML    940K 
14: EX-101.LAB  XBRL Labels -- dd-20170331_lab                       XML   1.57M 
15: EX-101.PRE  XBRL Presentations -- dd-20170331_pre                XML   1.03M 
11: EX-101.SCH  XBRL Schema -- dd-20170331                           XSD    201K 
81: ZIP         XBRL Zipped Folder -- 0000030554-17-000016-xbrl      Zip    251K 


‘EX-32.1’   —   Certification — §906 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Exhibit  


Exhibit 32.1
 
Certification of CEO Pursuant to
18 U.S.C. Section 1350,
As Adopted Pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002 
In connection with the Quarterly Report of E. I. du Pont de Nemours and Company (the “Company”) on Form 10-Q for the period ended March 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Edward D. Breen, as Chief Executive Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1)
The Report fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
 
Chief Executive Officer




Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:4/25/178-K
For Period end:3/31/178-K
 List all Filings 


1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/11/21  Corteva, Inc.                     10-K       12/31/20  196:32M
Top
Filing Submission 0000030554-17-000016   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., Apr. 30, 5:38:44.1pm ET